Healthy children younger than 12 years would not be permitted to consent to vaccination without parental approval. Children older than 9 years with underlying medical conditions for whom the vaccine could offer increased benefits, however, would be exempt from this general prohibition and, after an a...
(EUA) for the Company’s single-shot COVID-19 vaccine candidate for adults 18 and older, developed by the Janssen Pharmaceutical Companies ofJohnson & Johnson. The vote was based on a totality of scientific evidence provided by the Company, including ef...
Most patients with COVID-19 vaccine hesitancy were male (65.1%), younger than 44 years (57.5%), employed (47.2%), and had been diagnosed with HIV for less than one year (33%). However, no statistically significant differences were found between vaccinated patients and those with COVID-19...
Note that the multivariate models (b) used two sets of explanatory variables: for demographic characteristics, socioeconomic characteristics, virus type and vaccine status, the adjusted models accounted for health care utilization prior to the pandemic. While for health care utilization, the adjusted ...
Sinovac Biotech has reported that its Covid-19 vaccine, CoronaVac, obtained approval in Hong Kong for children aged six months to three years.
the vaccine is proven to be very safe for children (including in the long term, as yet unknown), and safer than the effects of the disease children are significant spreaders of infection (which does not appear to be the case for COVID-19, at least for pre-teens) ...
We assessed general vaccine hesitancy using the Korean version of the Vaccine Hesitancy Scale [19, 23]. The scale consists of seven items (e.g., childhood vaccines are important for my child's health) with 5-point Likert-type responses (1 = strongly agree to 5 = strongly disagree). We ...
More About Infectious Diseases Coronavirus (COVID-19) Bleeding and Transfusion open access Trending Estimated Vaccine Effectiveness and Respiratory Syncytial Virus–Related Lower Respiratory Tract Disease Research December 13, 2024 SARS-CoV-2 Nirmatrelvir Resistance—A Concern for Immunocompromised Populations...
Similarly, nearly four in every ten interviewees said to be concerned about health risks, while almost 36 percent considered not needing the vaccine against the disease due to a good health condition. Reasons for not getting vaccinated against COVID-19 in Spain as of Septembe...
In the meantime, I can’t help but refer to apost I did about a rare form of clotting disorderobserved at an even lower frequency after vaccination with the Johnson & Johnson vaccine (for which, by the way, no reports of myocarditis have yet surfaced the last time I checked) and Tweet...